Stratos Genomics

The firm said recent breakthroughs in its technology will enable sequencing "at commercially compelling levels of read length, accuracy, process speed, and workflow efficiency." 

Stratos reached its milestone by demonstrating nanopore sequencing with its proprietary expandable nucleotides, called X-NTPs.

CHICAGO (GenomeWeb) — Roche Diagnostics this week provided a window into its business strategy, particularly in the area of molecular diagnostics where, over the last several months, the company has made a number of moves designed to position itself as "the most comprehensive provider of solution

NEW YORK (GenomeWeb) – When Roche announced last month that it planned to acquire nanopore sequencing startup Genia for up to $350 million, unbeknownst to the public

NEW YORK (GenomeWeb) — Roche said today that it has made a strategic investment in nanopore sequencing startup Stratos Genomics and is collaborating to further develop the firm's sequencing chemistry.

NEW YORK (GenomeWeb) – Stratos Genomics has raised $10 million toward a Series B financing round targeting $16.3 million.

After developing the chemistry for its sequencing-by-expansion nanopore technology for several years, Stratos Genomics is ready to grow its development and commercialization efforts.

NEW YORK (GenomeWeb News) – Sequencing technology developer Stratos Genomics said today that it raised $2 million in Series A-5 financing in the fall of 2013.

Paired Ends: Todd Smith


Stratos Genomics has appointed Todd Smith to its science advisory board. Smith recently retired from PerkinElmer. Previously, he was president, CEO, and CTO of Geospiza, before it was acquired by PerkinElmer.

Stratos Genomics has appointed Tim Hunkapiller to its science advisory board. Hunkapiller is a co-inventor of Sanger sequencing technology.


Berkeley researchers have engineered yeast to make the molecule behind the hoppy taste of beer, Quartz reports.

King's College London researchers examine the influence of school type and genetics on academic achievement.

FiveThirtyEight writes that most who take a direct-to-consumer BRCA1/2 genetic test won't learn much from it.

In Science this week: early life experience influence somatic variation in the genome, and more.